-
Sermonix Pharmaceuticals’ Lasofoxifene Is Well Tolerated, Demonstrates Promising Ki67 Suppression in Phase 2 I-SPY 2 Arm Evaluating Therapy in Neoadjuvant Breast Cancer Setting
02 Nov 2024 13:00 GMT
… breast cancer, the investigational drug was well tolerated and … officer, has extensive experience in pharmaceutical drug commercialization. Simon Jenkins, Ph … of both Parke-Davis Pharmaceuticals and Warner-Lambert’s Pharmaceutical Division. Learn more …
-
Novel Drug Shows Benefits in Rare C3G and Primary IC-MPGN
29 Oct 2024 08:25 GMT
SAN DIEGO — The investigational drug pegcetacoplan, a C3/C3b … study, Matthias Kretzler, MD, the Warner-Lambert/Parke-Davis professor of … result in disease progression. The drug is already approved for the …
-
Sermonix Pharmaceuticals to Host Oral Presentation on Vaginal and Sexual Health at RISE UP for Breast Cancer Conference
21 Oct 2024 13:00 GMT
… lasofoxifene, its lead investigational drug. The Sermonix management team, … , has extensive experience in pharmaceutical drug commercialization. Simon Jenkins, Ph … of both Parke-Davis Pharmaceuticals and Warner-Lambert’s Pharmaceutical Division. Learn more …
-
Movie review: 'Kneecap' a sex-drug-and-politics history of Irish hip-hop trio
20 Sep 2024 05:59 GMT
… disappears one night.
Selling drugs that they order through … : Cheech-and-Chong-style drugged adventures (including a hallucinatory … . (Sept. 21, in theaters)
Warner Bros. / Everett Collection
‘ … her sister (voiced by Khaleesi Lambert-Tsuda) aboard, as well …
-
Sermonix Pharmaceuticals Completes Enrollment of Phase 2 I-SPY 2 Arm Evaluating Lasofoxifene in Neoadjuvant Breast Cancer Setting
27 Aug 2024 13:00 GMT
… lasofoxifene, its lead investigational drug, as a neoadjuvant endocrine … , has extensive experience in pharmaceutical drug commercialization. Simon Jenkins, Ph … of both Parke-Davis Pharmaceuticals and Warner-Lambert’s Pharmaceutical Division. Learn more …
-
US sanctions former Haitian President Martelly over drug trafficking allegations
20 Aug 2024 19:47 GMT
… Joseph Lambert and former Haitian Senator Youri Latortue, accusing them of drug … trafficking. Latortue vehemently denied the allegations. At the time, Lambert … Cable News Network, Inc., a Warner Bros. Discovery Company. All rights …
-
Vaxart Appoints Seasoned Biotech Executive Kevin Finney to Board of Directors
28 Jan 2025 13:00 GMT
… . (now Nestle Health Science), Amylin Pharmaceuticals, Inc. (now Bristol-Myers Squibb … the Parke-Davis division of Warner-Lambert (now Pfizer). In addition to …
-
Sermonix Pharmaceuticals Receives U.S. Patent for Lasofoxifene as Method for Treating Aromatase-Resistant ER+ Breast Cancer in the Absence of ESR1 Mutations
18 Jul 2024 13:00 GMT
… lasofoxifene, its lead investigational drug. The Sermonix management team, … , has extensive experience in pharmaceutical drug commercialization. Simon Jenkins, Ph … of both Parke-Davis Pharmaceuticals and Warner-Lambert’s Pharmaceutical Division. Learn more …
-
Sermonix Announces Clinical Breast Cancer Publication of Article Examining Effects of Lasofoxifene Versus Fulvestrant on Urogenital Symptoms in Patients with ESR1-Mutated ER+/HER2- Metastatic Breast Cancer
29 Jan 2025 15:19 GMT
… lasofoxifene, its lead investigational drug. The Sermonix management team, … , has extensive experience in pharmaceutical drug commercialization. Simon Jenkins, Ph … of both Parke-Davis Pharmaceuticals and Warner-Lambert’s Pharmaceutical Division. Learn more …
-
Sermonix Pharmaceuticals Announces Chinese Approval of Investigational New Drug Application for Lasofoxifene
06 Jun 2024 13:00 GMT
… NMPA) approved the investigational new drug application (IND) for oral … officer, has extensive experience in pharmaceutical drug commercialization. Simon Jenkins, Ph. … of both Parke-Davis Pharmaceuticals and Warner-Lambert’s Pharmaceutical Division. To learn …
About
© 1995-2025